Core Viewpoint - Huaxia Eye Hospital (301267) announced on September 26 that the new refractive surgery technique, Beijing Huaxia Minzhong All-Laser Femto 4.0, accounts for approximately 60% of refractive surgeries, excluding ICL implantation surgeries, indicating a significant market share and patient acceptance [1] Company Summary - The All-Laser Femto 4.0 technique offers higher precision compared to previous methods, with minimal price differences, leading to a higher acceptance rate among patients [1] - The company plans to introduce the new Zeiss minimally invasive All-Laser SMILE pro technology to further meet diverse patient needs in the future [1] Industry Summary - The adoption of advanced refractive surgery techniques like All-Laser Femto 4.0 reflects a growing trend in the ophthalmology sector towards more precise and patient-friendly surgical options [1]

长江商报消息 ●长江商报公益记者 李璟 通讯员 彭祎 22载公益初心不改 值得关注的是，本次活动的成功举办，是武汉大学附属爱尔眼科医院公益力量与"武汉市侨联志愿服务 总队"这一公益平台的一次有力联动。 据了解，2025年正值武汉大学附属爱尔眼科医院建院22周年。自成立以来，该院始终秉持"使所有人， 无论贫穷富裕，都享有眼健康的权利"的使命，在提供高品质医疗服务的同时，积极履行社会责任，长 期坚持开展各类公益行动，打破医疗资源壁垒，将便捷、优质的眼健康服务送到最需要的人群身边，用 实际行动守护大众的视觉健康。 本次22周年院庆系列公益活动，在惠及广大社区居民的基础上，特别将目光投向了为城市正常运行默默 奉献的特定群体。据了解，系列活动的受益人群将广泛覆盖各平台骑手、依托新技术、新业态、新模式 就业的"三新"领域从业者，以及"侨益关爱"志愿者、青年志愿者、教育志愿者、社区志愿者、文化志愿 者等各类公益志愿者群体。 武汉大学附属爱尔眼科医院相关负责人表示，22周年是一个新的起点，医院将继续坚守公益初心，不断 创新服务模式，扩大服务范围，通过更多元化的公益活动，将眼健康的种子播撒到更多角落，为提升全 民眼健康水平、建 ...

Core Viewpoint - He Eye Hospital experienced a decline of 1.67% in stock price on September 25, with a trading volume of 29.49 million yuan, indicating potential market concerns regarding the company's performance [1] Financing Summary - On September 25, He Eye Hospital had a financing buy-in amount of 4.36 million yuan and a financing repayment of 3.73 million yuan, resulting in a net financing buy of 0.63 million yuan [1] - The total financing and securities balance for He Eye Hospital reached 65.76 million yuan, with the financing balance accounting for 2.02% of the circulating market value, which is below the 50th percentile level over the past year, indicating a low financing position [1] - In terms of securities lending, there were no shares repaid or sold on September 25, with a remaining quantity of 100 shares and a securities lending balance of 2,065 yuan, which is above the 50th percentile level over the past year, suggesting a high securities lending position [1] Company Overview - He Eye Hospital Group, established on October 15, 2009, and listed on March 22, 2022, is located in Shenyang, Liaoning Province, and specializes in providing ophthalmic specialty diagnosis and treatment services [2] - The company's revenue composition includes: vision care services (30.24%), refractive surgery correction services (24.16%), non-surgical treatments (20.02%), cataract diagnosis and treatment services (13.68%), vitreoretinal diagnosis and treatment services (8.09%), other eye disease treatment services (3.20%), and other business income (0.61%) [2] - As of June 30, the number of shareholders increased by 15.03% to 10,800, while the average circulating shares per person decreased by 13.07% to 7,684 shares [2] Financial Performance - For the first half of 2025, He Eye Hospital reported a revenue of 560 million yuan, reflecting a year-on-year decrease of 4.22%, while the net profit attributable to shareholders was 44.32 million yuan, showing a significant year-on-year increase of 84.19% [2] Dividend Information - Since its A-share listing, He Eye Hospital has distributed a total of 348 million yuan in dividends, with 275 million yuan distributed over the past three years [3] Institutional Holdings - As of June 30, 2025, the sixth largest circulating shareholder of He Eye Hospital is Rongtong Health Industry Flexible Allocation Mixed A/B (000727), holding 2.79 million shares, which is a decrease of 1.76 million shares compared to the previous period [3]

Group 1: Business Structure and Revenue - The current revenue structure of Beijing Huaxia Minzhong Eye Hospital shows that refractive and optometry services account for approximately 40%, while cataract and other eye disease services account for about 60%. The hospital aims to increase the revenue share of refractive, optometry, and presbyopia services to 70%-80% in the future [2][3] - The proportion of new refractive surgical techniques, such as the all-laser femtosecond surgery (4.0), currently accounts for about 60% of refractive surgeries (excluding ICL implantation) [2][3] Group 2: Surgical Services and Market Trends - The volume of femtosecond cataract surgeries represents about 50% of the total cataract surgeries performed at the hospital. Despite being a fully self-funded service, patient acceptance is high due to the demand for superior visual experiences [3][4] - The medical payment system is evolving towards a combination of "medical insurance + commercial insurance + personal payment," which is a significant trend. The hospital focuses on differentiated services and technologies to meet patients' supplementary and enhanced medical needs, indicating strong market potential [3][4] Group 3: Competitive Advantages and Market Position - Beijing Huaxia Minzhong Eye Hospital has established a strong brand reputation in the Beijing market since its founding in 2008, supported by a dual-track expert model that includes both internal staff and renowned specialists [3][4] - The hospital has developed five major centers for various eye care services and possesses advanced diagnostic and treatment equipment, providing a competitive edge in expert resources, treatment capabilities, and academic research [3][4] Group 4: Future Goals and Development Plans - The hospital is one of six cities where Huaxia Eye Hospital Group plans to establish regional eye care centers. Future goals include optimizing revenue structure, introducing advanced technologies and equipment, and enhancing patient service levels to maintain a leading position in the high-end medical market in Beijing [4] - The new SMILE pro technique is being promoted across various hospitals under the group, with the Xiamen Eye Center achieving a milestone of 2,000 surgeries, making it the fastest single hospital to reach this number globally [4]

中国经济网北京9月25日讯 甘肃日报报业集团下属奔流新闻近期报道《爱尔眼科医院串换医保收费项目 医生投诉获2000元奖励》显示，9月12日，奔 流新闻记者从武汉市中心医院急诊科主任艾芬处获悉，她因投诉浙江象山爱尔眼科医院串换医保收费项目，获得象山县医疗保障局奖励2000元。 《象山县医疗保障局投诉举报奖励通知书》显示，该局于2025年5月19日受理艾芬投诉象山爱尔眼科医院串换医保收费项目的举报信。经查，在2023 年11月至2025年5月期间，该医院开设"目录外项目睑板腺检查串换成医保目录内项目角膜地形图检查收费"并纳入医保基金支付，存在串换项目收费的违法 行为，涉及违规费用45100元，造成医疗保障基金损失27826.70元，属实。根据浙江省相关办法，决定给予2000元人民币奖励。 南方都市报报道《象山爱尔眼科因骗保行为被罚逾13万元，举报人获奖励两千》显示，艾芬表示，近年来她已多次就多地爱尔眼科医院存在的违法违 规执业问题向有关部门进行反映，此次为第二次获得举报奖励。她强调，举报目的在于推动医疗机构规范运营，维护医保基金安全，奖励金额并非关注重 点。 象山县卫生健康局8月12日因象山爱尔眼科医院有限公司使 ...

Core Points - The "Light of Love" public medical project was launched in Uzbekistan from September 19 to 26, aiming to provide cataract surgeries for over a hundred impoverished patients [1][3] - The medical team from Huaxia Eye Hospital Group includes multidisciplinary experts in cataracts, retinal diseases, anesthesia, and nursing [1] - Since 2019, Chinese ophthalmologists have successfully completed nearly a thousand cataract surgeries in Uzbekistan, highlighting the ongoing medical cooperation between the two countries [1][3] Group 1 - The project is part of the "Belt and Road" initiative, promoting people-to-people connectivity and has benefited tens of thousands of patients since its inception in 2005 [3] - The Huaxia Eye Hospital Group has organized over ten medical missions to countries along the "Belt and Road" since 2014, completing more than 3,300 cataract surgeries [3] - The initiative aims not only to provide immediate medical assistance but also to leave behind sustainable medical capabilities through technology transfer [3]

Group 1 - The second International Civil Society Conference on Global Development Initiatives was held in Hohhot, co-hosted by the China International Exchange Promotion Association and the Inner Mongolia Autonomous Region Government, with He Eye Hospital Group invited to participate [1] - He Eye Hospital has been focusing on eye health for 30 years, leveraging innovative technology to build a comprehensive ecosystem in the eye health industry, aiming to create the "He Smart Bright City" [1] - He Eye Hospital is a member of the World Association of Eye Hospitals (WAEH) and actively participates in international training programs and foreign aid medical projects [1] Group 2 - Recently, He Eye Hospital has signed cooperation agreements with civil organizations from Malaysia, Pakistan, and Ethiopia to expand its international collaboration in public health within the eye health sector [2] - During the conference, He Eye Hospital signed a cooperation agreement with the Zambian Ministry of Health to enhance eye health services in Zambia through talent training, technology sharing, and innovative models [2] - He Eye Hospital aims to strengthen international cooperation in public health by sharing technology, exchanging talents, and providing public welfare services, contributing to the construction of a community with a shared future for mankind [2]

Core Insights - The second International Civil Society Conference on Global Development Initiative was held in Hohhot, Inner Mongolia, where He Eye Hospital was invited to showcase its international blindness prevention cooperation achievements [1][2] - He Eye Hospital aims to strengthen communication and cooperation with civil organizations worldwide in public health, leveraging technology sharing, talent exchange, and public service to create a replicable and sustainable eye health model [1] Group 1: Company Initiatives - He Eye Hospital has been deeply engaged in the eye health sector for 30 years, accumulating extensive experience in blindness prevention technologies and practices [1] - The company operates a comprehensive eye health ecosystem platform built on the "medical, education, industry, and research" model, with a strategic goal of establishing the "He Smart Light City" [1] - He Eye Hospital is a member of the World Association of Eye Hospitals (WAEH) and has played a significant role in international ophthalmology training and foreign aid medical projects [2] Group 2: International Collaborations - Recently, He Eye Hospital signed cooperation agreements with civil organizations from Malaysia, Pakistan, and Ethiopia, expanding its international public health cooperation network [2] - During the conference, a cooperation agreement was also signed with representatives from the Zambian Ministry of Health, focusing on talent training, technology sharing, and building blindness prevention models [2] - The hospital plans to utilize big data and artificial intelligence to enhance the quality of eye health services in Zambia, contributing to local capacity building [2]

Core Insights - The 12th Academic Conference of the Ophthalmology Professional Committee of Hubei Traditional Chinese Medicine Association was held in Enshi City, focusing on the theme "Inheritance and Innovation, Integration for a Bright Future" to promote the development of ophthalmology and traditional Chinese medicine [1][2] Group 1: Conference Highlights - The conference featured renowned experts sharing the latest research findings and clinical experiences, including Professor Kang Zefeng and Professor Xing Yiqiao [1] - An innovative segment titled "Jingming Lunjian: Master’s Diagnosis" allowed ophthalmology experts from various regions to present typical cases and treatment techniques, including a live diagnosis and treatment for a 64-year-old patient [1] Group 2: Educational Initiatives - A "Classics Understanding - Traditional Chinese Ophthalmology Knowledge Competition" was organized to assess participants' understanding of classical literature and clinical applications, enhancing professional skills [2] - In the "Diligent Learning Techniques - New Technology Exchange" section, experts discussed topics such as "Balanced Immunity, Optimal Protection" and "Clinical Application of Integrated Chinese and Western Medicine in Dry Eye Treatment" [2] Group 3: Institutional Progress - Enshi Central Hospital has made significant advancements in medical technology, research innovation, talent cultivation, and service capabilities in ophthalmology, becoming the first national clinical key specialty in the region [2] - The hospital aims to continue enhancing its research and clinical service levels, particularly in areas like myopia prevention, cataract recovery, and refractive surgery, contributing to the health of Enshi and Hubei [2]

Core Viewpoint - The announcement indicates that the controlling shareholder, Guangzheng Investment, has pledged 64.6 million shares, representing 50.01% of its holdings and 12.46% of the company's total share capital, to Shenzhen Hangjia Source Holdings for operational purposes [1] Summary by Relevant Sections - **Pledge Details** - Guangzheng Investment has pledged 64.6 million shares with a pledge period from September 22, 2025, to September 22, 2027 [1] - On September 23, 34.9199 million shares were released from pledge [1] - **Financial Implications** - The total pledged shares correspond to a financing balance of 130 million yuan within the next two years [1] - Guangzheng Investment's credit and financial status are reported to be good, with no risk of forced liquidation or transfer of pledged shares [1] - **Impact on the Company** - The current pledge is stated to have no impact on the company [1]